loadpatents
name:-0.032665014266968
name:-0.011537790298462
name:-0.007249116897583
Wang; Zhuozhi Patent Filings

Wang; Zhuozhi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wang; Zhuozhi.The latest application filed is for "novel bispecific cd3/cd20 polypeptide complexes".

Company Profile
9.14.29
  • Wang; Zhuozhi - Millbrae CA
  • Wang; Zhuozhi - Shanghai CN
  • WANG; Zhuozhi - Burlingame CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Monoclonal antibodies to programmed death 1 (PD-1)
Grant 11,414,487 - Zheng , et al. August 16, 2
2022-08-16
Bispecific CD3/CD19 polypeptide complexes
Grant 11,365,254 - Liu , et al. June 21, 2
2022-06-21
Humanized monoclonal antibodies against activated protein c and uses thereof
Grant RE49,099 - Zhao , et al. June 7, 2
2022-06-07
Novel Bispecific Cd3/cd20 Polypeptide Complexes
App 20220162312 - CHEN; Yunying ;   et al.
2022-05-26
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20220041752 - WANG; Zhuozhi ;   et al.
2022-02-10
A Novel Anti-cd3/anti-cd20 Bispecific Antibody
App 20210380710 - CHEN; Yunying ;   et al.
2021-12-09
Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)
Grant 11,078,281 - Wang , et al. August 3, 2
2021-08-03
Novel Bispecific Pd-1/lag-3 Antibody Molecules
App 20210115138 - Wang; Zhuozhi ;   et al.
2021-04-22
Novel Monoclonal Antibodies To Cytotoxic T-lymphocyte-associated Protein 4 (ctla-4)
App 20210040214 - WANG; Zhuozhi ;   et al.
2021-02-11
Bispecific antibodies against EGFR and PD-1
App 20200354460 - WANG; Zhuozhi ;   et al.
2020-11-12
Novel Bispecific Cd3/cd19 Polypeptide Complexes
App 20200283523 - LIU; Jieying ;   et al.
2020-09-10
Novel Bispecific Polypeptide Complexes
App 20200283524 - XU; Jianqing ;   et al.
2020-09-10
Novel Monoclonal Antibodies To Cytotoxic T-lymphocyte-associated Protein 4 (ctla-4)
App 20200277377 - WANG; Zhuozhi ;   et al.
2020-09-03
The Novel Monoclonal Antibodies To Programmed Death 1 (pd-1)
App 20200002420 - ZHENG; Yong ;   et al.
2020-01-02
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20190194353 - WANG; Zhuozhi ;   et al.
2019-06-27
Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
Grant RE47,150 - Wang , et al. De
2018-12-04
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20180334509 - WANG; Zhuozhi ;   et al.
2018-11-22
Anti-tfpi Antibody Variants With Differential Binding Across Ph Range For Improved Pharmacokinetics
App 20180282430 - Murphy; John E. ;   et al.
2018-10-04
Protease-regulated Antibodies
App 20180251570 - WANG; Zhuozhi ;   et al.
2018-09-06
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20180194857 - WANG; Zhuozhi ;   et al.
2018-07-12
Thrombin/plasmin-regulated antibodies that bind TFPI
Grant 9,975,962 - Wang , et al. May 22, 2
2018-05-22
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20170342162 - WANG; Zhuozhi ;   et al.
2017-11-30
Monospecific And Multispecific Antibodies And Method Of Use
App 20170210825 - LIU; Bing ;   et al.
2017-07-27
Humanized monoclonal antibodies against activated protein C and uses thereof
Grant 9,657,111 - Zhao , et al. May 23, 2
2017-05-23
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20170107298 - WANG; Zhuozhi ;   et al.
2017-04-20
Monospecific and multispecific antibodies and method of use
Grant 9,624,309 - Liu , et al. April 18, 2
2017-04-18
Anti-TFPI antibody variants with differential binding across PH range for improved pharmacokinetics
Grant 9,556,280 - Murphy , et al. January 31, 2
2017-01-31
Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
Grant 9,309,324 - Wang , et al. April 12, 2
2016-04-12
Pro-drug Antibodies Against Tissue Factor Pathway Inhibitor
App 20160009817 - WANG; Zhuozhi ;   et al.
2016-01-14
Humanized Monoclonal Antibodies Against Activated Protein C And Uses Thereof
App 20150322164 - ZHAO; Xiao-Yan ;   et al.
2015-11-12
MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C (aPC)
App 20150307625 - ZHAO; Xiao-Yan ;   et al.
2015-10-29
Protease-regulated Antibodies
App 20150064169 - Wang; Zhuozhi ;   et al.
2015-03-05
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor (tfpi)
App 20140294832 - Wang; Zhuozhi ;   et al.
2014-10-02
Anti-tfpi Antibody Variants With Differential Binding Across Ph Range For Improved Pharmacokinetics
App 20140275493 - Murphy; John E. ;   et al.
2014-09-18
Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
Grant 8,481,030 - Wang , et al. July 9, 2
2013-07-09
Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI)
App 20120329996 - Wang; Zhuozhi ;   et al.
2012-12-27
Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor
App 20120269817 - Wang; Zhuozhi ;   et al.
2012-10-25
Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI)
App 20120108796 - WANG; Zhuozhi ;   et al.
2012-05-03
Monospecific And Multispecific Antibodies And Method Of Use
App 20110229476 - Liu; Bing ;   et al.
2011-09-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed